Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (146)
- COVID-19 (144)
- Prescription medicines (129)
- Regulatory compliance (120)
- COVID-19 vaccines (88)
- Legislation (78)
- Therapeutic goods regulation (71)
- Listed medicines (48)
- Non-prescription medicines (43)
- Medical devices safety (42)
- Safety (40)
- Vaping hub (33)
- Complementary medicines (30)
- Manufacturing (28)
- Assessed listed medicines (24)
- Labelling and packaging (22)
- Over the counter (OTC) medicines (21)
- Compliance and enforcement hub (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (17)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1052 result(s) found, displaying 151 to 175
-
NewsFrom 30 November 2023, some sports supplements will be regulated as therapeutic goods and must be included in the Australian Register of Therapeutic Goods (ARTG).
-
NewsWe are aware that a small number of people have received calls from scammers impersonating the TGA.
-
NewsFind out about changes to choline salicylate access, starting from October 2023.
-
NewsThe COVID-19 pandemic post-market review of facemasks is now finished.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesOn 29 August 2023, the TGA executed multiple warrants on storage units and residences in Brisbane and seized over 40,000 vaping products with an estimated street value of over $1.2 million
-
NewsFind out how Product Information inserts won’t be required in the packaging of injectable medicines, given by health professionals, starting from September 2023.
-
Media releasesWe have issued infringement notices for $26,640 to Nius Development Pty Ltd for the alleged unlawful import of unapproved cosmetic injectable products.
-
Media releasesThe TGA has issued 7 infringement notices totalling $115,500 to the company for the alleged unlawful advertising and supply of sport supplement products containing banned substances.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsCompanies supplying medicines in Australia will be required to provide additional information if their products go into shortage.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued five infringement notices totalling $82,500 were issued to the company, and 3 notices totalling $9,900 were issued to an individual.
-
NewsRead about our import, advertising and supply compliance priorities for 2023-24.
-
Safety updatesUnderstand the Medicines Safety Update for July 2023 - Information for health professionals and consumers.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesFind out how the prescribing and dispensing requirements for MS-2 Step have changed.
-
Media releasesWe have issued 8 infringement notices totalling $105,600 to Nature’s Puff Pty Ltd and a director, for the alleged unlawful advertising of nicotine vaping products.
-
Media releasesThis International Coalition of Medicines Regulatory Authorities (ICMRA) statement provides the general public with important information regarding the safety of COVID-19 vaccines, which have now been in use for more than two years.
-
NewsIf you're a sponsor, it's important to be aware of the global issue of nitrosamine impurities in medicines. Find out what steps you should take.
-
NewsThe Government has agreed that regulatory amendments should be drafted to extend the transition arrangements for certain medical device reforms to 1 July 2029.
-
NewsStay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.
-
NoticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the latest Therapeutic Goods (Permissible Ingredients) Determination.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.